Paying user area
Try for free
Biogen Inc. pages available for free this week:
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Geographic Areas
- Price to FCFE (P/FCFE)
- Selected Financial Data since 2005
- Net Profit Margin since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Biogen Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Current share price (P) | |
No. shares of common stock outstanding | |
US$ in thousands | |
Common equity (market value)1 | |
Add: Preferred stock, par value $0.001 per share (per books) | |
Add: Noncontrolling interests (per books) | |
Total equity | |
Add: Current portion of notes payable (per books) | |
Add: Notes payable, excluding current portion (per books) | |
Total equity and debt | |
Less: Cash and cash equivalents | |
Less: Marketable securities | |
Enterprise value (EV) |
Based on: 10-K (reporting date: 2021-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Biogen Inc. Annual Report.
3 2021 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Biogen Inc. EV decreased from 2019 to 2020 and from 2020 to 2021. |